Table 1.

Demographic and clinical information

		n = (of 15)
Psychiatric diagnosis:	Schizophrenia	8
	Schizoaffective disorder	6
	Delusional disorder	1
Current level of support:	Independent accommodation, outpatient care	2
	Independent accommodation, community team	8
	Independent accommodation, daily support	2
	Supported accommodation	1
	Acute mental health ward	2
Psychotropic medications prescribed:	Hypnotics	1
	Mood stabilisers	5
	Anti-depressants	9
	At least one antipsychotic	15
	One antipsychotic	8
	Two antipsychotics	7
	Oral antipsychotics, no depota	11
	Depot and oral antipsychotics	3
	Depot antipsychotic, no oral antipsychotic	1
	Clozapineb	2
Antipsychotic dosage (as a fraction of DDDc)	Range	0.36–5.5
	Median / mean (SDd)	2 / 2.19 (1.28)
Gender:	% male	67%
Age:	Range	23–69 years
	Median / mean (SD)	44 / 45.9 (10.55)
GAF-F score (functioning)e:	Range	38–85
	Median / mean (SD)	65 / 62.3 (12.16)
GAF-S score (symptoms)e:	Range	21–80
	Median / mean (SD)	39/ 47.7 (19.40)

^aLong-acting intramuscular injection, typically given every 1–4 weeks. ^bSpecified separately as only used in otherwise treatment resistant illness. ^cThe defined daily dose (DDD) is the assumed average maintenance dose per day for a drug used for its main indication in adults. [98] ^dStandard Deviation. ^eScores may range from 1 to 100, lower scores = more impairment